Ofri Mosenzon

Ofri Mosenzon

UNVERIFIED PROFILE

Are you Ofri Mosenzon?   Register this Author

Register author
Ofri Mosenzon

Ofri Mosenzon

Publications by authors named "Ofri Mosenzon"

Are you Ofri Mosenzon?   Register this Author

38Publications

1112Reads

-Profile Views

Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial).

Am J Cardiol 2019 Jan 26;123(1):145-152. Epub 2018 Sep 26.

TIMI Study Group, Boston, Massachusetts; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.09.014DOI Listing
January 2019

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2019 01 10;380(4):347-357. Epub 2018 Nov 10.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital (S.D.W., M.P.B., T.A.Z., J.F.K., S.A.M., D.L.B., C.T.R., M.S.S.), and the Cardiology Division, Massachusetts General Hospital (M.G.S.) - both in Boston; the Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem (I.R., O.M., A.C.); the Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan (E.T.K.); Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.); the Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom (J.P.H.W.); and AstraZeneca Gothenburg, Mölndal, Sweden (I.A.M.G.-N., M.F., P.A.J., A.-M.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812389DOI Listing
January 2019

Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial.

Diabetes Obes Metab 2018 12 10;20(12):2885-2893. Epub 2018 Oct 10.

Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13545DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231963PMC
December 2018

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.

Eur Heart J 2018 Jun;39(24):2255-2262

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, MA, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/eurheartj/article/39/24/2255/483124
Publisher Site
http://dx.doi.org/10.1093/eurheartj/ehx809DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012971PMC
June 2018

DECLARE-TIMI 58: Participants' baseline characteristics.

Diabetes Obes Metab 2018 05 14;20(5):1102-1110. Epub 2018 Feb 14.

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13217DOI Listing
May 2018

LEADER-6: Baseline renal function and associated factors in a high cardiovascular risk type 2 diabetes population.

J Diabetes Complications 2016 Nov - Dec;30(8):1631-1639. Epub 2016 Jun 3.

Department of Nephrology, Hypertension & Rheumatology, Friedrich Alexander University of Erlangen, Munchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2016.06.001DOI Listing
March 2018

Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease.

Diabetes Care 2018 03 1;41(3):577-585. Epub 2017 Dec 1.

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc17-1736DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829964PMC
March 2018

Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome study.

Diabetes Obes Metab 2017 07 8;19(7):1045-1050. Epub 2017 Mar 8.

Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12903DOI Listing
July 2017

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.

Diabetes Care 2017 Jan 17;40(1):69-76. Epub 2016 Oct 17.

Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc16-0621DOI Listing
January 2017

Improvement in Glucose Control in Difficult-to-Control Patients With Diabetes Using a Novel Flash Glucose Monitoring Device.

J Diabetes Sci Technol 2016 11 1;10(6):1412-1413. Epub 2016 Nov 1.

Diabetes Unit, Hadassah University Hospital, Jerusalem, Israel

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1932296816653412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094332PMC
November 2016

Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial.

Diabetes Care 2016 Aug 23;39(8):1329-37. Epub 2016 May 23.

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc15-2763DOI Listing
August 2016

Treatment of Type 2 Diabetes: From "Guidelines" to "Position Statements" and Back: Recommendations of the Israel National Diabetes Council.

Diabetes Care 2016 Aug;39 Suppl 2:S146-53

Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dcS15-3003DOI Listing
August 2016

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.

Am J Med 2016 Mar 31;129(3):340.e1-8. Epub 2015 Oct 31.

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Heart and Vascular Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2015.09.022DOI Listing
March 2016

Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial.

Diabetes Care 2015 Nov 10;38(11):2142-50. Epub 2015 Sep 10.

Diabetes Unit, Hadassah-Hebrew University Hospital, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc15-1068DOI Listing
November 2015

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.

Circulation 2014 Oct 4;130(18):1579-88. Epub 2014 Sep 4.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division (B.M.S., E.B., M.A.C., D.A.M., K.I., A.A.U.-E., D.L.B.) and Department of Pathology (P.J.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Diabetes Unit (I.R., O.M.), Division of Internal Medicine, Hadassah Hebrew University Hospital, Jerusalem, Israel; Cardiovascular Division (J.A.U.), Women's College Hospital and Toronto General Hospital, University of Toronto, Toronto, Canada; AstraZeneca Research and Development (P.S.P., B.H.), Gaithersburg, MD; Bristol-Myers Squibb (R.F.), Princeton, NJ; Cardiovascular Research Institute (B.S.L.), Lady Davis Carmel Medical Center and Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Cardiovascular Medicine (D.K.M.) and Division of Endocrinology, Department of Internal Medicine (J.D.), University of Texas Southwestern Medical Center, Dallas, TX; University Hospital Department (G.S.), Département Hospitalo-Universitaire FIRE (Fibrosis, Inflammation, Remodelling), Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 1148, Université Paris-Diderot, and Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France (P.G.S.), Imperial College, Institute of Cardiovascular Medicine and Science, Royal Brompton Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.114.010389DOI Listing
October 2014

Early insulinization to prevent diabetes progression.

Diabetes Care 2013 Aug;36 Suppl 2:S190-7

Diabetes Unit, Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dcS13-2014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920803PMC
August 2013

Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs: when and for whom?

Diabetes Care 2013 Aug;36 Suppl 2:S212-8

Diabetes Unit, Department of Internal Medicine, Hadassah University Hospital, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dcS13-2007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920792PMC
August 2013

Spontaneous tumor lysis syndrome in solid tumors: really a rare condition?

Am J Med Sci 2003 Jan;325(1):38-40

Department of Medicine 'A', Western Galilee Hospital, Naharya, Israel.

View Article

Download full-text PDF

Source
January 2003